These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 33230386)

  • 1. Molecular targets and system biology approaches for drug repurposing against SARS-CoV-2.
    Singh RK; Yadav BS; Mohapatra TM
    Bull Natl Res Cent; 2020; 44(1):193. PubMed ID: 33230386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repurposing novel therapeutic candidate drugs for coronavirus disease-19 based on protein-protein interaction network analysis.
    Adhami M; Sadeghi B; Rezapour A; Haghdoost AA; MotieGhader H
    BMC Biotechnol; 2021 Mar; 21(1):22. PubMed ID: 33711981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A network biology approach to identify crucial host targets for COVID-19.
    Barman RK; Mukhopadhyay A; Maulik U; Das S
    Methods; 2022 Jul; 203():108-115. PubMed ID: 35364279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug Repurposing for COVID-19: A Review and a Novel Strategy to Identify New Targets and Potential Drug Candidates.
    Rodrigues L; Bento Cunha R; Vassilevskaia T; Viveiros M; Cunha C
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35566073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applying polypharmacology approach for drug repurposing for SARS-CoV2.
    Jamir E; Sarma H; Priyadarsinee L; Nagamani S; Kiewhuo K; Gaur AS; Rawal RK; Murugan NA; Subramanian V; Sastry GN
    J Chem Sci (Bangalore); 2022; 134(2):57. PubMed ID: 35498548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling repurposable drug combinations against COVID-19 by developing the heterogeneous deep herb-graph method.
    Yang F; Zhang S; Pan W; Yao R; Zhang W; Zhang Y; Wang G; Zhang Q; Cheng Y; Dong J; Ruan C; Cui L; Wu H; Xue F
    Brief Bioinform; 2022 Sep; 23(5):. PubMed ID: 35514205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host transcriptome-guided drug repurposing for COVID-19 treatment: a meta-analysis based approach.
    Loganathan T; Ramachandran S; Shankaran P; Nagarajan D; Mohan S S
    PeerJ; 2020; 8():e9357. PubMed ID: 32566414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of complemented comprehensive networks for rapid screening of repurposable drugs applicable to new emerging disease outbreaks.
    Nam Y; Lucas A; Yun JS; Lee SM; Park JW; Chen Z; Lee B; Ning X; Shen L; Verma A; Kim D
    J Transl Med; 2023 Jun; 21(1):415. PubMed ID: 37365631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico drug repurposing against SARS-CoV-2 using an integrative transcriptomic profiling approach: Hydrocortisone and Benzhydrocodone as potential drug candidates against COVID-19.
    Mirmohammadi S; Kianmehr A; Sabbaghian A; Mohebbi A; Shahbazmohammadi H; Sheykharabi M; Bazzi Z
    Infect Genet Evol; 2022 Sep; 103():105318. PubMed ID: 35718334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging strategies on in silico drug development against COVID-19: challenges and opportunities.
    Yadav M; Dhagat S; Eswari JS
    Eur J Pharm Sci; 2020 Dec; 155():105522. PubMed ID: 32827661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches.
    Ahmed FF; Reza MS; Sarker MS; Islam MS; Mosharaf MP; Hasan S; Mollah MNH
    PLoS One; 2022; 17(4):e0266124. PubMed ID: 35390032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network bioinformatics analysis provides insight into drug repurposing for COVID-19.
    Li X; Yu J; Zhang Z; Ren J; Peluffo AE; Zhang W; Zhao Y; Wu J; Yan K; Cohen D; Wang W
    Med Drug Discov; 2021 Jun; 10():100090. PubMed ID: 33817623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of novel coronavirus disease (COVID-19): based on genomic structure, phylogeny, current shreds of evidence, candidate vaccines, and drug repurposing.
    Kumar SU; Priya NM; Nithya SR; Kannan P; Jain N; Kumar DT; Magesh R; Younes S; Zayed H; Doss CGP
    3 Biotech; 2021 Apr; 11(4):198. PubMed ID: 33816047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug Repurposing Approach against Novel Coronavirus Disease (COVID-19) through Virtual Screening Targeting SARS-CoV-2 Main Protease.
    Chowdhury KH; Chowdhury MR; Mahmud S; Tareq AM; Hanif NB; Banu N; Reza ASMA; Emran TB; Simal-Gandara J
    Biology (Basel); 2020 Dec; 10(1):. PubMed ID: 33374717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications.
    Ting CT; Chen BS
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung disease network reveals impact of comorbidity on SARS-CoV-2 infection and opportunities of drug repurposing.
    Das AB
    BMC Med Genomics; 2021 Sep; 14(1):226. PubMed ID: 34535131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Consensus Analysis of SARS-CoV-2 Drug Repurposing Campaigns.
    Mslati H; Gentile F; Perez C; Cherkasov A
    J Chem Inf Model; 2021 Aug; 61(8):3771-3788. PubMed ID: 34313439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.
    Abdurrahman L; Fang X; Zhang Y
    Curr Mol Med; 2022; 22(7):621-639. PubMed ID: 34645374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2.
    Niranjan V; Setlur AS; Karunakaran C; Uttarkar A; Kumar KM; Skariyachan S
    Struct Chem; 2022; 33(5):1585-1608. PubMed ID: 35938064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.